News
SHANGHAI, July 22, 2025 - Eshallgo Inc. ("Eshallgo" or the "Company") (Nasdaq: EHGO), a leading provider of integrated office solutions in China, today announced ...
Analysts have set 12-month price targets for Jazz Pharmaceuticals, revealing an average target of $176.12, a high estimate of $202.00, and a low estimate of $147.00. Highlighting a 4.67% decrease, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results